Amphastar Pharmaceuticals, Inc.
$1.32B- Market cap
- $986.03M
- Debt
- +$619.71M
- Cash
- −$282.81M
Capital structure 61% equity / 39% debt · EV / Revenue 1.84x · EV / EBITDA 6.20x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
AMPH · current priceP/E 11.42x
$23.18Latest market snapshot
Implied fair value · at AZZ's multiple
$27.0716.8% above market
2.03 AMPH EPS (TTM)×13.34x AZZ P/E=$27.07
Market $23.18Implied $27.07
AZZ · current priceP/E 13.34x
$140.02Latest market snapshot
Implied fair value · at AMPH's multiple
$119.9014.4% below market
10.50 AZZ EPS (TTM)×11.42x AMPH P/E=$119.90
Market $140.02Implied $119.90